유니온바이오메트릭스
Financials
Valuation Metrics
유니온바이오메트릭스's Market Cap is ₩334B. At end of 2025 it was ₩439B. Ranked #1996 of 2,436 in KR market (top 82%), #1261 of 1,649 on KOSDAQ (top 76%), #192 of 246 in Technology Hardware & Equipment (top 78%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 33.37B KRW | KR#1,996/2,436 Sec#192/246 |
| Revenue | 49.89B KRW | KR#1,781/2,436 Sec#182/246 |
| Net Income | 1.40B KRW | KR#1,403/2,436 Sec#133/246 |
| Total Assets | 63.88B KRW | KR#2,046/2,436 Sec#212/246 |
| Net Assets | 40.74B KRW | KR#2,013/2,436 Sec#201/246 |
| Employees | 140 | KR#1,369/2,436 Sec#111/246 |
| Value | ||
| P/E | 23.80x | KR#1,173/2,436 Sec#106/246 |
| P/B | 0.82x | KR#1,311/2,436 Sec#133/246 |
| P/S | 0.67x | KR#1,126/2,436 Sec#113/246 |
| FCF Yield | -37.82% | KR—/2,436 Sec—/246 |
| Profitability | ||
| ROE | 3.44% | KR#1,178/2,436 Sec#118/246 |
| ROA | 2.19% | KR#1,107/2,436 Sec#118/246 |
| Op. Margin | -1.32% | KR#1,698/2,436 Sec#161/246 |
| Revenue Growth | -11.15% | KR#1,908/2,436 Sec#182/246 |
| Earnings Growth | -66.43% | KR#1,274/2,436 Sec#115/246 |
| Financial Health | ||
| Debt Ratio | 156.82% | KR#1,281/2,436 Sec#135/246 |
| Total Debt | 19.00B KRW | KR#1,373/2,436 Sec#133/246 |
| FCF | -12.62B KRW | KR#1,781/2,436 Sec#177/246 |
| Cash | 6.49B KRW | KR#1,891/2,436 Sec#203/246 |
| Current Ratio | 2.60x | KR#717/2,436 Sec#90/246 |
| Dividend | ||
| Div. Yield | 3.90% | KR#464/2,436 Sec#30/246 |
| Div. Growth | 28.57% | KR#363/2,436 Sec#30/246 |
| Performance | ||
| 1Y Return | -27.19% | KR#1,494/2,436 Sec#163/246 |
| 1M Return | -9.71% | KR#1,742/2,436 Sec#156/246 |
| From 52W High | -40.30% | KR#767/2,436 Sec#56/246 |
| 1Y MDD | -36.71% | KR#394/2,436 Sec#26/246 |
| Trading | ||
| Volume | 16,981 shares | KR#1,927/2,436 Sec#203/246 |
| Foreign Own. | 8.53% | KR#534/2,436 Sec#53/246 |
| Per Share | ||
| EPS | 100 KRW | KR#1,357/2,436 Sec#127/246 |
| BPS | 3,403 KRW | KR#1,726/2,436 Sec#172/246 |
Company Info
This company, a specialized biometric enterprise established in 2000, is pursuing global business by changing its company name to Union Biometrics in 2025 and establishing a corporation in Dubai, UAE. It possesses original biometric technologies, including fingerprint and facial recognition, and develops and sells access controllers, fingerprint recognition modules, and bio information. The company has secured 207 intellectual property rights and technical personnel, leading the security authentication market by expanding global partnerships based on globally recognized technology. Union Biometrics was established in 2000 and is headquartered in Songpa-gu, Seoul.